Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer halts study of lymphoma drug unlikely to help survival
Pfizer halts study of lymphoma drug unlikely to help survival
Pfizer halts study of lymphoma drug unlikely to help survival
Submitted by
admin
on May 21, 2013 - 10:08am
Source:
Reuters
News Tags:
Pfizer
inotuzumab
non-Hodgkin's lymphoma
Headline:
Pfizer halts study of lymphoma drug unlikely to help survival
Do Not Allow Advertisers to Use My Personal information
